Hua Yang

发表

2-Methoxydiol derivatives as new tubulin and HDAC dual-targeting inhibitors, displaying antitumor and antiangiogenic response.

Yixin Zhang, Y. Duan, Mo-ran Sun, 2022, Bioorganic chemistry.

Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8).

C. Zhang, S. Ghosh, B. Jaffee, 2006, Journal of medicinal chemistry.

Design, Synthesis and Biological Evaluation of Novel Etoposide Analogues as Cytotoxic Agents

Hua Yang, Ying-Qian Liu, X. Tian, 2006 .

Synthesis and Insecticidal Activities of New Ether-Derivatives of Celangulin-V

Zhaonong Hu, Hua Yang, Wenjun Wu, 2010, Natural Product Communications.

Design, synthesis, and structure-activity relationships of substituted piperazinone-based transition state factor Xa inhibitors.

J. Woolfrey, B. Zhu, Hua Yang, 2003, Bioorganic & medicinal chemistry letters.

Design, synthesis, biological evaluation and structure-activity relationship study of quinazolin-4(3H)-one derivatives as novel USP7 inhibitors.

Hong-min Liu, Hua Yang, Y. Liu, 2021, European journal of medicinal chemistry.

Discovery of novel tubulin/HDAC dual-targeting inhibitors with strong antitumor and antiangiogenic potency.

Yixin Zhang, Y. Duan, Jinling Qin, 2021, European journal of medicinal chemistry.

Effects of survivin on FVADT chemotherapy for refractory multiple myeloma.

Hua Yang, Xingjun Du, Y. Xi, 2016, Experimental and therapeutic medicine.

Design, synthesis, and structure-activity relationships of unsubstituted piperazinone-based transition state factor Xa inhibitors.

B. Zhu, Hua Yang, A. Arfsten, 2003, Bioorganic & medicinal chemistry letters.